Xylem (XYL) NDR Takeaways Reveal Pricing Escalators Likely Cushion Recent Cost Increases - Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Connor Lynagh reiterated an Overweight rating and $100.00 price target on Xylem (NYSE: XYL) after hosting CFO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
